1,748
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Predictive value of the albumin-bilirubin grade on long-term outcomes of CT-guided percutaneous microwave ablation in intrahepatic cholangiocarcinoma

, , , , &
Pages 327-335 | Received 22 Oct 2018, Accepted 07 Jan 2019, Published online: 28 Jan 2019

Figures & data

Table 1. Baseline characteristics of the patients.

Table 2. Characteristics of the patients stratified by ALBI grade.

Figure 1. Representative pictures of the patient with ICC after CT-PMWA. (a&b): Pre-PMWA MRI images (A: contrast-enhanced T1WI; B:T2WI); (c&d): Two images of plain CT scan during PMWA procedure show the well location of PMWA electrode probes; (e–g): Post-PMWA MRI images (contrast-enhanced TIWI) at 6-month(e), 1-year(f), and 3-year(g), respectively.

Figure 1. Representative pictures of the patient with ICC after CT-PMWA. (a&b): Pre-PMWA MRI images (A: contrast-enhanced T1WI; B:T2WI); (c&d): Two images of plain CT scan during PMWA procedure show the well location of PMWA electrode probes; (e–g): Post-PMWA MRI images (contrast-enhanced TIWI) at 6-month(e), 1-year(f), and 3-year(g), respectively.

Table 3. Factors associating with the overall survival of patients.

Table 4. Factors associating with the recurrence-free survival of patients.

Figure 2. (A): Graph shows the cumulative 1-, 3- and 5-year overall survival rates of patients with ICCs after CT-guided PMWA treatment based on the Child score. (B): Graph shows the cumulative 1-, 3- and 5-year overall survival rates of patients with ICCs after CT-guided PMWA treatment based on the ALBI grade.

Figure 2. (A): Graph shows the cumulative 1-, 3- and 5-year overall survival rates of patients with ICCs after CT-guided PMWA treatment based on the Child score. (B): Graph shows the cumulative 1-, 3- and 5-year overall survival rates of patients with ICCs after CT-guided PMWA treatment based on the ALBI grade.

Figure 3. (A): Graph shows the cumulative 1-, 3- and 5-year overall survival rates of patients with a hepatic function of child score 5 after CT-guided PMWA treatment based on the ALBI grade. (B): Graph shows the cumulative 1-, 3- and 5-year overall survival rates of patients with a hepatic function of child score 6 after CT-guided PMWA treatment based on the ALBI grade.

Figure 3. (A): Graph shows the cumulative 1-, 3- and 5-year overall survival rates of patients with a hepatic function of child score 5 after CT-guided PMWA treatment based on the ALBI grade. (B): Graph shows the cumulative 1-, 3- and 5-year overall survival rates of patients with a hepatic function of child score 6 after CT-guided PMWA treatment based on the ALBI grade.

Figure 4. (A): Graph shows the cumulative 1-, 3- and 5-year recurrence-free survival rates of patients with ICCs after CT-guided PMWA treatment based on the child score. (B): Graph shows cumulative 1-, 3- and 5-year recurrence-free survival rates of patients with ICCs after CT-guided PMWA treatment based on the ALBI grade.

Figure 4. (A): Graph shows the cumulative 1-, 3- and 5-year recurrence-free survival rates of patients with ICCs after CT-guided PMWA treatment based on the child score. (B): Graph shows cumulative 1-, 3- and 5-year recurrence-free survival rates of patients with ICCs after CT-guided PMWA treatment based on the ALBI grade.